Category: Biologics
Global Biologics
-
Veterinary Excipients Market Size, Trends, Analysis, and Outlook By Application(Biologics, Pharmaceuticals, Medicated Feed Additives)By Chemical Group(Polymers, Alcohols, Lipids, Mineral Salts, Others)By Animal Type(Production Animals, Companion Animals)By Function(Solubilizers/Solvents, Binders, Stabilizers, Coating, Diluents & Fillers, Others), by Region, Country, Segment, and Companies, 2024-2030
... Region, Country, Segment, and Companies, 2024-2030 The global Veterinary Excipients market size is poised to register 6.73% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Viral Vectors and Plasmid DNA Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Adenovirus, Retrovirus, Adeno-Associated Virus (AAV), Lentivirus, Plasmids, Others), By Manufacturing (Upstream Manufacturing (Vector Amplification & Expansion, Vector Recovery/Harvesting), Downstream Manufacturing (Purification, Fill Finish)), By Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Fill Finish)), By Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), by Region, Country, Segment, ... Read More
-
Ulcerative Colitis Market Size, Trends, Analysis, and Outlook By Drug Type (Anti-Inflammatory Drugs, Aminosalicylates, Corticosteroids, Anti-TNF biologics, Immunosuppressants, Calcineurin Inhibitors, Others), By Disease (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, Fulminant Colitis), by Region, Country, Segment, and Companies, 2024-2030
... Region, Country, Segment, and Companies, 2024-2030 The global Ulcerative Colitis market size is poised to register 5.45% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Veterinary Medicine Market Size, Trends, Analysis, and Outlook By Animal Type (Production Animals, Companion Animals), By Product (Biologics, Pharmaceuticals, Medicated Feed Additives), By Route of Administration (Oral, Injectable, Topical, Others), By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Offline Retail Stores, Others), by Region, Country, Segment, and Companies, 2024-2030
... & Clinics, E-commerce, Offline Retail Stores, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Veterinary Medicine market size is poised to register 8.5% growth from 2024 to 2030, presenting significant growth prospects for ... Read More
-
Cancer Gene Therapy Market Size, Trends, Analysis, and Outlook By Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), By End-User (Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Others), by Region, Country, Segment, and Companies, 2024-2030
... global Cancer Gene Therapy market size is poised to register 20.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cancer Gene Therapy ... Read More
-
Serum-free Media Market Size, Trends, Analysis, and Outlook By Product (Classical Media, Specialty Media, Stem Cell Media, Others), By End-user (Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, Others), By Application (Bioproduction, Vaccine Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Others), By Animal Origin, Animal-derived Serum-Free Media, Plant-derived Serum-Free Media, Synthetic Serum-Free Media), By Distribution Channel (Direct Sales, Distributor), by Region, Country, Segment, and Companies, 2024-2030
... Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Others), By Animal Origin, Animal-derived Serum-Free Media, Plant-derived Serum-Free Media, Synthetic Serum-Free Media), By Distribution Channel (Direct Sales, Distributor), by Region, Country, Segment, and Companies, 2024-2030 ... Read More
-
Veterinary CRO And CDMO Market Size, Trends, Analysis, and Outlook By Animal Type (Companion Animals, Livestock Animals), By ServiceType, Discovery, Development, Manufacturing, Packaging & Labeling, Market Approval & Post-Marketing), By Application (Pharmaceuticals, Biologics, Medical Devices), by Region, Country, Segment, and Companies, 2024-2030
... by Region, Country, Segment, and Companies, 2024-2030 The global Veterinary CRO And CDMO market size is poised to register 8.54% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. ... Read More
-
Viral Vector Contract Development Manufacturing Organizations Market Size, Trends, Analysis, and Outlook By Vector (Adenovirus, Retrovirus, Adeno-Associated Virus, Lentivirus, Others), By Workflow (Upstream Manufacturing, Downstream Manufacturing), By Application (Antisense & RNAi Therapy, Gene Therapy-, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical & Biopharmaceutical Companies, Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical & Biopharmaceutical Companies, Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global Viral Vector Contract Development Manufacturing Organizations market size is poised to register 14.5% growth ... Read More
-
Veterinary Orthopedic Medicine Market Size, Trends, Analysis, and Outlook By Product Type (Biologics (Stem Cells, Platelet-Rich Plasma (PRP), Monoclonal Antibody, Viscosupplements), Pharmaceuticals (Steroids, NSAIDS, Others)), By Animal Type (Canine, Feline, Equine, Cattle, Swine, Others), By Application (Osteoarthritis, Degenerative Joint Disease, Joint Inflammation/Pain, Others), By Route of Administration (Oral, Parenteral, Topical), By End-user ( Veterinary Hospitals, Veterinary Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... Application (Osteoarthritis, Degenerative Joint Disease, Joint Inflammation/Pain, Others), By Route of Administration (Oral, Parenteral, Topical), By End-user ( Veterinary Hospitals, Veterinary Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Veterinary Orthopedic Medicine ... Read More
-
Fetal Bovine Serum Market Size, Trends, Analysis, and Outlook By Product (Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Others), By Application (Biopharmaceuticals, Cell Culture Media, Human and Animal Vaccine Production, Others), By End-User (Research and Academic Institutes, Biotechnology and Pharmaceutical Industry, Others), by Region, Country, Segment, and Companies, 2024-2030
... By End-User (Research and Academic Institutes, Biotechnology and Pharmaceutical Industry, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Fetal Bovine Serum market size is poised to register 7.41% growth from 2024 to 2030, ... Read More
-
Laboratory Proficiency Testing Market Size, Trends, Analysis, and Outlook By Industry (Clinical Diagnostics, Microbiology, Food & Animal Feed, Commercial Beverages, Environmental, Pharmaceuticals, Water, Nutraceuticals, Biologics, Cannabis/Opioids, Dietary Supplements, Cosmetics), By Technology (Cell Culture, PCR, Immunoassays, Chromatography, Spectrophotometry, Others), by Region, Country, Segment, and Companies, 2024-2030
... Chromatography, Spectrophotometry, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Laboratory Proficiency Testing market size is poised to register 6.96% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
AAV Contract Development and Manufacturing Organizations Market Size, Trends, Analysis, and Outlook By Workflow (Upstream Processing, Downstream Processing), By Type (Adherent Culture, Suspension Culture), By Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical and Pharmaceutical Discovery, Biomedical Research), By End-user (Pharmaceutical and Biopharmaceutical Companies, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Pharmaceutical Discovery, Biomedical Research), By End-user (Pharmaceutical and Biopharmaceutical Companies, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global AAV Contract Development and Manufacturing Organizations market size is poised to register ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Related Biologics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Third Party Logistics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biologic Therapeutic Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Therapeutic-Protein Biological Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Biological Safety Testing
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Logistics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Biopharmaceuticals
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Biologic Imaging Reagents
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Anti-Inflammatory Biologics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Wound Biologics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Interleukin Inhibitors
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Regenerative Bone and Joint Medicines
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Monoclonal Antibody Biopharmaceuticals
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
